Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Eoganachton May 02, 2024 11:01am
196 Views
Post# 36019535

RE:sigh

RE:sighHi DJDawg - I also hope we will be getting some longer term data as time goes on. 52 patients will have hit the 24 month milestone by the end of 2024. I hope they make that data available as I believe it will show a far better durable response than the competition.

There are some clues as to the hold up in today's news release in the description of the roles of the new employees, but, of course, it's not ideal to have to look for clues to understand the current situation.

3. Reviewing and analyzing the existing clinical data to ensure accuracy.
 
4. Securing review ethics board approval and patient consent to obtain patient clinical data up to 3 years from date of primary Study Procedure
 
5. Providing training and support on central pathology analysis of urine cytology and bladder biopsy pathology samples.
 
DJDawg wrote: What a long process. I wish there were more clarity on the company about what parts take so long. In general I don't mind being patient but I do mind the black void of information where we hear nothing more than that the quarter for BTD has been bumped (again).

I wish TLT were a company that wasn't public and we were all initial investors that didn't have to watch the depressing price action.

The way I see it, there are traders who seem to swing trade a lot of shares back and forth (still under the the same overall ownership I suspect) and create price fear without losing any of their shares since such a low volume stock. The BIGGEST thing that this pattern relies on is fear and the absence of any new information for a while. If this all the information for a while then the price will continue to fall, not because the majority of holders are selling, but because of this back and forth stock volume.

The only things that will prop up the current price, IMO, are:
- patient data update that shows CR's further out that they have collected. 540 on onwards. If they said BTD not ready yet but here is some more data showing that the CRs continue as we expect, that would bump up confidence.
- an update on GBM such as selection of MAB, sites. Something concrete.
- JV announcement of some kind

Without any updates, I fear the price will continue to fall which makes me sad as I'm a big believer in the science but feel disappointed in the black void of non-information about what makes this so slow or why they cannot get money from other sources.



<< Previous
Bullboard Posts
Next >>